Effective date
Medicare changes effective December 19, 2017
3 CMS and MAC policy updates take effect on this date. Every entry links to the government document it came from.
Fewer than 5 updates — this date is not listed in the index.
FDA · 3
- FDA Approval: STEGLUJAN (ERTUGLIFLOZIN AND SITAGLIPTIN) — Type 4 - New Combination
FDA-NDA209805NationalMulti-specialtysource ↗
- FDA Approval: STEGLATRO (ERTUGLIFLOZIN) — Type 1 - New Molecular Entity
FDA-NDA209803NationalMulti-specialtysource ↗
- FDA Approval: SEGLUROMET (ERTUGLIFLOZIN AND METFORMIN HYDROCHLORIDE) — Type 4 - New Combination
FDA-NDA209806NationalEndocrinologysource ↗